"World's Most Complete Market Research Reports Repository"

Global Transthyretin Amyloidosis (ATTR) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • Category : Healthcare & Pharma
  • |
  • ID : 675292
  • |
  • Publishe Date : 6-Nov-18
  • |
  • No of Pages: 117
  • |
  • Publisher : Global Info Research

Transthyretin Amyloidosis (ATTR) is an autosomal dominant hereditary disease that occurs due to deposition of variant TTR (transthyretin) protein in humans. It is mainly characterized into two main types i.e. Hereditary ATTR (hATTR) and Wild-Type (wt) ATTR. While Hereditary ATTR is caused by point mutations within TTR allele, wild-type ATTR is caused by the misfolding of Wild-Type TTR. Major prevalence of Hereditary ATTR is observed in the 7MM, and this type has been further sub-classified into Familial Amyloidosis Polyneuropathy (FAP) and Familial Amyloidosis Cardiomyopathy (FAC).



Scope of the Report:

This report studies the Transthyretin Amyloidosis (ATTR) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Transthyretin Amyloidosis (ATTR) market by product type and applications/end industries.

United States?accounts for highest ATTR Amyloidosis Cases, followed by EU5 (Italy, France, Spain,?Germany,?UK) and?Japan.

The global Transthyretin Amyloidosis (ATTR) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Transthyretin Amyloidosis (ATTR).

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.



Market Segment by Companies, this report covers

Pfizer

Alnylam Pharmaceuticals

Ionis Pharmaceuticals

Corino Therapeutics

Proclara Bioscience?

Arcturus Therapeutics



Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)



Market Segment by Type, covers

Hereditary ATTR (HATTR)

Wild-Type (WT) ATTR



Market Segment by Applications, can be divided into

Hospitals

Ambulatory Surgical Centers

Diagnostic Centers

Table of Contents



1 Transthyretin Amyloidosis (ATTR) Market Overview

1.1 Product Overview and Scope of Transthyretin Amyloidosis (ATTR)

1.2 Classification of Transthyretin Amyloidosis (ATTR) by Types

1.2.1 Global Transthyretin Amyloidosis (ATTR) Revenue Comparison by Types (2017-2023)

1.2.2 Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Types in 2017

1.2.3 Hereditary ATTR (HATTR)

1.2.4 Wild-Type (WT) ATTR

1.3 Global Transthyretin Amyloidosis (ATTR) Market by Application

1.3.1 Global Transthyretin Amyloidosis (ATTR) Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Diagnostic Centers

1.4 Global Transthyretin Amyloidosis (ATTR) Market by Regions

1.4.1 Global Transthyretin Amyloidosis (ATTR) Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Transthyretin Amyloidosis (ATTR) Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Transthyretin Amyloidosis (ATTR) Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Transthyretin Amyloidosis (ATTR) Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Transthyretin Amyloidosis (ATTR) Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Transthyretin Amyloidosis (ATTR) Status and Prospect (2013-2023)

1.5 Global Market Size of Transthyretin Amyloidosis (ATTR) (2013-2023)

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Business Overview

2.1.2 Transthyretin Amyloidosis (ATTR) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)

2.2 Alnylam Pharmaceuticals

2.2.1 Business Overview

2.2.2 Transthyretin Amyloidosis (ATTR) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)

2.3 Ionis Pharmaceuticals

2.3.1 Business Overview

2.3.2 Transthyretin Amyloidosis (ATTR) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)

2.4 Corino Therapeutics

2.4.1 Business Overview

2.4.2 Transthyretin Amyloidosis (ATTR) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Corino Therapeutics Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)

2.5 Proclara Bioscience?

2.5.1 Business Overview

2.5.2 Transthyretin Amyloidosis (ATTR) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Proclara Bioscience? Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)

2.6 Arcturus Therapeutics

2.6.1 Business Overview

2.6.2 Transthyretin Amyloidosis (ATTR) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)

3 Global Transthyretin Amyloidosis (ATTR) Market Competition, by Players

3.1 Global Transthyretin Amyloidosis (ATTR) Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Transthyretin Amyloidosis (ATTR) Players Market Share

3.2.2 Top 10 Transthyretin Amyloidosis (ATTR) Players Market Share

3.3 Market Competition Trend

4 Global Transthyretin Amyloidosis (ATTR) Market Size by Regions

4.1 Global Transthyretin Amyloidosis (ATTR) Revenue and Market Share by Regions

4.2 North America Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

4.3 Europe Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

4.5 South America Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

5 North America Transthyretin Amyloidosis (ATTR) Revenue by Countries

5.1 North America Transthyretin Amyloidosis (ATTR) Revenue by Countries (2013-2018)

5.2 USA Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

5.3 Canada Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

5.4 Mexico Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

6 Europe Transthyretin Amyloidosis (ATTR) Revenue by Countries

6.1 Europe Transthyretin Amyloidosis (ATTR) Revenue by Countries (2013-2018)

6.2 Germany Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

6.3 UK Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

6.4 France Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

6.5 Russia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

6.6 Italy Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue by Countries

7.1 Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue by Countries (2013-2018)

7.2 China Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

7.3 Japan Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

7.4 Korea Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

7.5 India Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

8 South America Transthyretin Amyloidosis (ATTR) Revenue by Countries

8.1 South America Transthyretin Amyloidosis (ATTR) Revenue by Countries (2013-2018)

8.2 Brazil Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

8.3 Argentina Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

8.4 Colombia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Transthyretin Amyloidosis (ATTR) by Countries

9.1 Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue by Countries (2013-2018)

9.2 Saudi Arabia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

9.3 UAE Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

9.4 Egypt Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

9.5 Nigeria Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

9.6 South Africa Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

10 Global Transthyretin Amyloidosis (ATTR) Market Segment by Type

10.1 Global Transthyretin Amyloidosis (ATTR) Revenue and Market Share by Type (2013-2018)

10.2 Global Transthyretin Amyloidosis (ATTR) Market Forecast by Type (2018-2023)

10.3 Hereditary ATTR (HATTR) Revenue Growth Rate (2013-2023)

10.4 Wild-Type (WT) ATTR Revenue Growth Rate (2013-2023)

11 Global Transthyretin Amyloidosis (ATTR) Market Segment by Application

11.1 Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Application (2013-2018)

11.2 Transthyretin Amyloidosis (ATTR) Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)

11.5 Diagnostic Centers Revenue Growth (2013-2018)

12 Global Transthyretin Amyloidosis (ATTR) Market Size Forecast (2018-2023)

12.1 Global Transthyretin Amyloidosis (ATTR) Market Size Forecast (2018-2023)

12.2 Global Transthyretin Amyloidosis (ATTR) Market Forecast by Regions (2018-2023)

12.3 North America Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)

12.4 Europe Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)

12.6 South America Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Transthyretin Amyloidosis (ATTR) Picture

Table Product Specifications of Transthyretin Amyloidosis (ATTR)

Table Global Transthyretin Amyloidosis (ATTR) and Revenue (Million USD) Market Split by Product Type

Figure Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Types in 2017

Figure Hereditary ATTR (HATTR) Picture

Figure Wild-Type (WT) ATTR Picture

Table Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Application (2013-2023)

Figure Transthyretin Amyloidosis (ATTR) Revenue Market Share by Applications in 2017

Figure Hospitals Picture

Figure Ambulatory Surgical Centers Picture

Figure Diagnostic Centers Picture

Table Global Market Transthyretin Amyloidosis (ATTR) Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (2013-2023)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Transthyretin Amyloidosis (ATTR) Type and Applications

Table Pfizer Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)

Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Type and Applications

Table Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)

Table Ionis Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Type and Applications

Table Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)

Table Corino Therapeutics Basic Information, Manufacturing Base and Competitors

Table Corino Therapeutics Transthyretin Amyloidosis (ATTR) Type and Applications

Table Corino Therapeutics Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)

Table Proclara Bioscience? Basic Information, Manufacturing Base and Competitors

Table Proclara Bioscience? Transthyretin Amyloidosis (ATTR) Type and Applications

Table Proclara Bioscience? Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)

Table Arcturus Therapeutics Basic Information, Manufacturing Base and Competitors

Table Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Type and Applications

Table Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Revenue, Gross Margin and Market Share (2016-2017)

Table Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Players (2013-2018)

Table Global Transthyretin Amyloidosis (ATTR) Revenue Share by Players (2013-2018)

Figure Global Transthyretin Amyloidosis (ATTR) Revenue Share by Players in 2016

Figure Global Transthyretin Amyloidosis (ATTR) Revenue Share by Players in 2017

Figure Global Top 5 Players Transthyretin Amyloidosis (ATTR) Revenue Market Share in 2017

Figure Global Top 10 Players Transthyretin Amyloidosis (ATTR) Revenue Market Share in 2017

Figure Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Regions (2013-2018)

Table Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Regions (2013-2018)

Figure Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Regions (2013-2018)

Figure Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Regions in 2017

Figure North America Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure Europe Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure South America Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Table North America Transthyretin Amyloidosis (ATTR) Revenue by Countries (2013-2018)

Table North America Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2013-2018)

Figure North America Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2013-2018)

Figure North America Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries in 2017

Figure USA Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure Canada Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure Mexico Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Table Europe Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Countries (2013-2018)

Figure Europe Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2013-2018)

Figure Europe Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries in 2017

Figure Germany Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure UK Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure France Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure Russia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure Italy Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries in 2017

Figure China Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure Japan Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure Korea Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure India Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Table South America Transthyretin Amyloidosis (ATTR) Revenue by Countries (2013-2018)

Table South America Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2013-2018)

Figure South America Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2013-2018)

Figure South America Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries in 2017

Figure Brazil Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure Argentina Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure Colombia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue Market Share by Countries in 2017

Figure Saudi Arabia Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure UAE Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure Egypt Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure Nigeria Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Figure South Africa Transthyretin Amyloidosis (ATTR) Revenue and Growth Rate (2013-2018)

Table Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) by Type (2013-2018)

Table Global Transthyretin Amyloidosis (ATTR) Revenue Share by Type (2013-2018)

Figure Global Transthyretin Amyloidosis (ATTR) Revenue Share by Type (2013-2018)

Figure Global Transthyretin Amyloidosis (ATTR) Revenue Share by Type in 2017

Table Global Transthyretin Amyloidosis (ATTR) Revenue Forecast by Type (2018-2023)

Figure Global Transthyretin Amyloidosis (ATTR) Market Share Forecast by Type (2018-2023)

Figure Global Hereditary ATTR (HATTR) Revenue Growth Rate (2013-2018)

Figure Global Wild-Type (WT) ATTR Revenue Growth Rate (2013-2018)

Table Global Transthyretin Amyloidosis (ATTR) Revenue by Application (2013-2018)

Table Global Transthyretin Amyloidosis (ATTR) Revenue Share by Application (2013-2018)

Figure Global Transthyretin Amyloidosis (ATTR) Revenue Share by Application (2013-2018)

Figure Global Transthyretin Amyloidosis (ATTR) Revenue Share by Application in 2017

Table Global Transthyretin Amyloidosis (ATTR) Revenue Forecast by Application (2018-2023)

Figure Global Transthyretin Amyloidosis (ATTR) Market Share Forecast by Application (2018-2023)

Figure Global Hospitals Revenue Growth Rate (2013-2018)

Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2013-2018)

Figure Global Diagnostic Centers Revenue Growth Rate (2013-2018)

Figure Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Transthyretin Amyloidosis (ATTR) Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Transthyretin Amyloidosis (ATTR) Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)

Figure Europe Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)

Figure South America Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Transthyretin Amyloidosis (ATTR) Revenue Market Forecast (2018-2023)

Choose License Type